HPV persistence: An overlooked consequence of helminth infection?
HPV 持续存在:蠕虫感染的一个被忽视的后果?
基本信息
- 批准号:8030117
- 负责人:
- 金额:$ 18.35万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-01-11 至 2012-12-31
- 项目状态:已结题
- 来源:
- 关键词:AIDS preventionAdultAftercareAgeAreaCancer BurdenCancer EtiologyCervicalCervical Cancer ScreeningCountryDataEarly DiagnosisEvaluationFemaleGenital systemHPV-High RiskHelminthsHigh PrevalenceHuman PapillomavirusHuman papilloma virus infectionImmuneIncidenceInfectionInterruptionInterventionIntestinesLesionMalignant neoplasm of cervix uteriMucosal ImmunityNatural HistoryPeruPrevalencePreventionPrevention strategyProphylactic treatmentRegulatory T-LymphocyteReproductive HealthResidual stateResourcesScreening procedureSoilSourceVaccinationWomanagedbasecarcinogenesiscell mediated immune responsecervical cancer preventioncostcytokineinterestmortalityneoplasticpreventprophylacticreproductivevaccine evaluation
项目摘要
DESCRIPTION (provided by applicant): Cervical cancer, caused by persistent infection with high risk human papillomavirus (HR-HPV) infection, remains the second leading cause of cancer in women in the world. Vaccines and screening are effective prevention measures, but are simply unaffordable in the countries with the greatest need. We are therefore interested in identifying modifiable factors associated with increased HPV prevalence and persistence as targets for low cost interventions in areas where HPV screening and vaccination are unlikely to be economically feasible. An ecological correlation is observed between regions with high cervical cancer incidence and high soil-transmitted helminth (STH) burden. We hypothesize that the well-known Th2-shift associated with intestinal helminth infection results in a decreased cell-mediated immune response to HPV infection, leading to higher prevalence and burden of multiple HPV infection in helminth-endemic regions. We therefore aim to determine the association between helminth infection and HPV prevalence and burden of multiple infections in women aged 25-45 years in low and high helminth endemic regions of Peru. We will also compare the distribution of cervical Th1/Th2/Treg cytokines in HPV positive vs. HPV negative women and in helminth negative vs. helminth positive women. As a subaim, women found to be infected with helminthes will be treated and HPV prevalence and cervical immune profiles compared before and after treatment. If our hypothesis is proven correct, periodic deforming, at a cost of US $0.21 - US $0.51 per treatment, would offer a highly affordable alternative to reducing the HR-HPV and cervical cancer burden in many resource-poor regions. Furthermore, a comprehensive evaluation of cervical cytokine profiles in reproductive age women from helminth-endemic and non-endemic regions of Peru will provide critical new data that may have a broader impact in areas including reproductive health and HIV prevention.
PUBLIC HEALTH RELEVANCE: Cervical cancer, caused by persistent infection with high risk human papillomavirus (HR-HPV) infection, remains the second leading cause of cancer in women in the world. Vaccines and screening are effective prevention measures, but are simply unaffordable in the countries with the greatest need. We hypothesize that the well-known Th2-shift associated with intestinal helminth infection results in a decreased cell-mediated immune response to HPV infection, leading to higher prevalence and burden of multiple HPV infection in helminth-endemic regions. If our hypothesis is proven correct, periodic deworming, at a cost of US $0.21 - US $0.51 per treatment, would offer a highly affordable alternative to reducing the HR-HPV and cervical cancer burden in many resource-poor regions.
描述(申请人提供):宫颈癌是由高危人乳头瘤病毒(HR-HPV)持续感染引起的,仍然是世界上女性第二大癌症原因。 疫苗和筛查是有效的预防措施,但在最需要的国家根本负担不起。 因此,我们有兴趣确定与 HPV 患病率和持续性增加相关的可改变因素,作为在 HPV 筛查和疫苗接种在经济上不太可行的地区进行低成本干预的目标。 在宫颈癌发病率高和土源性蠕虫(STH)负担高的地区之间观察到了生态相关性。 我们假设与肠道蠕虫感染相关的众所周知的 Th2 转变会导致细胞介导的针对 HPV 感染的免疫反应降低,从而导致蠕虫流行地区多种 HPV 感染的患病率和负担更高。 因此,我们的目标是确定秘鲁蠕虫低流行区和高蠕虫流行区 25-45 岁女性中蠕虫感染与 HPV 患病率和多重感染负担之间的关系。 我们还将比较 HPV 阳性与 HPV 阴性女性以及蠕虫阴性与蠕虫阳性女性中宫颈 Th1/Th2/Treg 细胞因子的分布。 作为一个子目标,将对发现感染蠕虫的女性进行治疗,并比较治疗前后的 HPV 患病率和宫颈免疫特征。 如果我们的假设被证明是正确的,周期性变形术每次治疗的费用为 0.21 美元 - 0.51 美元,将为许多资源匮乏地区减少 HR-HPV 和宫颈癌负担提供一种非常实惠的替代方案。 此外,对秘鲁蠕虫流行区和非流行区育龄妇女的宫颈细胞因子谱进行全面评估将提供重要的新数据,可能对生殖健康和艾滋病毒预防等领域产生更广泛的影响。
公共卫生相关性:宫颈癌是由高危人乳头瘤病毒 (HR-HPV) 持续感染引起的,仍然是世界上女性癌症的第二大原因。 疫苗和筛查是有效的预防措施,但在最需要的国家根本负担不起。 我们假设与肠道蠕虫感染相关的众所周知的 Th2 转变会导致细胞介导的针对 HPV 感染的免疫反应降低,从而导致蠕虫流行地区多种 HPV 感染的患病率和负担更高。 如果我们的假设被证明是正确的,那么定期驱虫,每次治疗的费用为 0.21 美元 - 0.51 美元,将为许多资源匮乏地区减少 HR-HPV 和宫颈癌负担提供一种非常实惠的替代方案。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PATTI E GRAVITT其他文献
PATTI E GRAVITT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PATTI E GRAVITT', 18)}}的其他基金
Translating Molecular Diagnostics for Cervical Cancer Prevention into Practice
将宫颈癌预防的分子诊断转化为实践
- 批准号:
9028945 - 财政年份:2016
- 资助金额:
$ 18.35万 - 项目类别:
Translating Molecular Diagnostics for Cervical Cancer Prevention into Practice
将宫颈癌预防的分子诊断转化为实践
- 批准号:
9330126 - 财政年份:2016
- 资助金额:
$ 18.35万 - 项目类别:
HPV persistence: An overlooked consequence of helminth infection?
HPV 持续存在:蠕虫感染的一个被忽视的后果?
- 批准号:
8212141 - 财政年份:2011
- 资助金额:
$ 18.35万 - 项目类别:
HPV Infection Among Perimenopausal Women in the 1945-64 Birth Cohor
1945-64 出生群体中围绝经期妇女的 HPV 感染情况
- 批准号:
7259764 - 财政年份:2007
- 资助金额:
$ 18.35万 - 项目类别:
HPV Infection Among Perimenopausal Women in the 1945-64 Birth Cohor
1945-64 出生群体中围绝经期妇女的 HPV 感染情况
- 批准号:
8038440 - 财政年份:2007
- 资助金额:
$ 18.35万 - 项目类别:
HPV Infection Among Perimenopausal Women in the 1945-64 Birth Cohor
1945-64 出生群体中围绝经期妇女的 HPV 感染情况
- 批准号:
8533529 - 财政年份:2007
- 资助金额:
$ 18.35万 - 项目类别:
HPV Infection Among Perimenopausal Women in the 1945-64 Birth Cohor
1945-64 出生群体中围绝经期妇女的 HPV 感染情况
- 批准号:
7589736 - 财政年份:2007
- 资助金额:
$ 18.35万 - 项目类别:
HPV Infection Among Perimenopausal Women in the 1945-64 Birth Cohor
1945-64 出生群体中围绝经期妇女的 HPV 感染情况
- 批准号:
7413665 - 财政年份:2007
- 资助金额:
$ 18.35万 - 项目类别:
HPV Infection Among Perimenopausal Women in the 1945-64 Birth Cohor
1945-64 出生群体中围绝经期妇女的 HPV 感染情况
- 批准号:
7789551 - 财政年份:2007
- 资助金额:
$ 18.35万 - 项目类别:
A Mixed Methods Study of STI Co-Infections and Cervical Immune Microenvironment (
STI 合并感染与宫颈免疫微环境的混合方法研究(
- 批准号:
8769915 - 财政年份:
- 资助金额:
$ 18.35万 - 项目类别:
相似国自然基金
单核细胞产生S100A8/A9放大中性粒细胞炎症反应调控成人Still病发病及病情演变的机制研究
- 批准号:82373465
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
成人型弥漫性胶质瘤患者语言功能可塑性研究
- 批准号:82303926
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
- 批准号:82302160
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
SERPINF1/SRSF6/B7-H3信号通路在成人B-ALL免疫逃逸中的作用及机制研究
- 批准号:82300208
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于动态信息的深度学习辅助设计成人脊柱畸形手术方案的研究
- 批准号:82372499
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Study to establish safety, tolerability and feasibility of LM11A-31 as a neuroprotective agent in aging people living with HIV and neurocognitive impairment on antiretroviral therapy
研究确定 LM11A-31 作为神经保护剂对老年艾滋病毒感染者和抗逆转录病毒治疗神经认知障碍患者的安全性、耐受性和可行性
- 批准号:
10762833 - 财政年份:2023
- 资助金额:
$ 18.35万 - 项目类别:
PHASE I STUDY OF PHARMACOKINETICS, SAFETY AND ACCEPTABILITY OF A SINGLE DOSE OF PRETOMANID ADDED TO AN OPTIMIZED BACKGROUND REGIMEN IN CHILDREN WITH RIFAMPICIN RESISTANT TUBERCULOSIS IMPAACT 2034
对患有利福平耐药结核病儿童的单剂量 Pretomanid 的药代动力学、安全性和可接受性的 I 期研究添加到优化背景方案中的影响 2034
- 批准号:
10679271 - 财政年份:2022
- 资助金额:
$ 18.35万 - 项目类别:
HIV Vaccines Clinical Trials Network Leadership and Operations Center
HIV 疫苗临床试验网络领导和运营中心
- 批准号:
10311601 - 财政年份:2021
- 资助金额:
$ 18.35万 - 项目类别:
Zikhethele - choose for you: evaluating choice-based antiretroviral therapy support for patients returning to HIV care after treatment interruption in South Africa
Zikhethele - 为您选择:评估对南非治疗中断后返回艾滋病毒护理的患者的基于选择的抗逆转录病毒治疗支持
- 批准号:
10472733 - 财政年份:2021
- 资助金额:
$ 18.35万 - 项目类别:
Zikhethele - choose for you: evaluating choice-based antiretroviral therapy support for patients returning to HIV care after treatment interruption in South Africa
Zikhethele - 为您选择:评估对南非治疗中断后返回艾滋病毒护理的患者的基于选择的抗逆转录病毒治疗支持
- 批准号:
10612080 - 财政年份:2021
- 资助金额:
$ 18.35万 - 项目类别: